Catalyst Wire Dossier Catalyst Wire Dossier

Sunphenon Epigallocatechin-gallate (EGCg)

epigallocatechin-gallate · Sunphenon
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sunphenon Epigallocatechin-gallate (EGCg), covering 2021-07-29 to 2021-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study) [Phase 1, Phase 2]

See pricing